Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms
Richard P. Baum, Harshad R. Kulkarni, Aviral Singh, Daniel Kaemmerer, Dirk Mueller, Vikas Prasad, Merten Hommann, Franz C. Robiller, Karin Niepsch, Franz Holger, Arthur Jochems, Philippe Lambin, Dieter Horsch*
Research output: Contribution to journal › Article › Academic › peer-review
58Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms'. Together they form a unique fingerprint.